Abstract
Recurrent abdominal pain and recurrent pancreatitis are common problems associated with some patients with cystic fibrosis (CF). There is no known effective method to prevent recurrent abdominal pain and recurrent pancreatitis in such patients. The objective of this study was to determine whether nocturnal hydration (NH) prevents recurrent abdominal pain and recurrent acute pancreatitis in patients with adult-onset CF. Adult CF patients who were referred to our Pancreatic Diseases Clinic for recurrent abdominal pain and pancreatitis were enrolled in the study. Each patient was encouraged to drink plenty of water during the night and established a 6-month diary (3 months before and 3 months after NH was initiated), recording the frequency and severity of their abdominal pain, the amount of pain medication taken, and the volume of their water intake. We also reviewed the number of doctor's clinic visits, emergency room visits, and hospitalizations for about 1 year before and 1 year after the initiation of the NH. The frequency and the severity of abdominal pain in this group of patients were significantly reduced. The amount of pain medication and the number of emergency room visits and hospitalizations for abdominal pain and acute pancreatitis were reduced. NH is a simple and cost-effective method to prevent recurrent abdominal pain and pancreatitis in patients with adult-onset CF.
Similar content being viewed by others
References
Ratjen F, Doring G (2003) Cystic fibrosis. Lancet 361:681–689
Witt DR, Schaefer C, Hallam P, Wi S, Blumberg B, Fishbach A, Holtzman J, Kornfeld S, Lee R, Nemzer L, Palmer R (1996) Cystic fibrosis heterozygote screening in 5,161 pregnant women. Am J Hum Genet 58:823–835
Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N (1989) Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245:1059–1065
Liddle RA, Cohn JA (1995) Hereditary diseases of the pancreas. In: Yamada T, et al. (eds) Textbook of gastroenterology, 2nd edn. Lippincott Williams & Wlikins, Philadelphia, PA, pp 2161– 2173
Rosner B (2000) Fundamentals of biostatistics, 5th edn. Duxbury Press, Pacific Grove, CA
Rowntree RK, Harris A (2003) The phenotypic consequences of CFTR mutations. Ann Hum Genet 67:471–485
Groman JD, Meyer ME, Wilmott RW, Zeitlin PL, Cutting GR (2002) Variant cystic fibrosis 7. phenotypes in the absence of CFTR mutations. N Engl J Med 347:401–407
Cohn JA, Friedman KJ, Noone PG, Knowles MR, Silverman LM, Jowell PS (1998) Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 339:653–658
Sharer N, Schwarz M, Malone G, Howarth A, Painter J, Super M, Braganza J (1998) Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 339:645–652
Lyon E, Miller C (2003) Current challenges in cystic fibrosis screening. Arch Pathol Lab Med 127:1133–1139
Kerem E, Kerem B (1996) Genotype-phenotype correlations in cystic fibrosis. Pediatr Pulmonol 22:387–395
Zielenski J (2000) Genetype and phenotype in cystic fibrosis. Respiration 67:117–133
Durno C, Corey M, Zielenski J, Tullis E, Tsui LC, Durie P (2002) Genotype and phenotype. Gastroenterology 123:1857–1864
Taylor CJ, Aswani N (2002) The pancreas in cystic fibrosis. Pediatr Respir Rev 3:77–81
Shwachman H, Lebenthal E, Khaw KT (1975) Recurrent acute pancreatitis in patients with cystic fibrosis with normal pancreatic enzymes. Pediatrics 55:86
Gilljam M, Ellis L, Corey M, Zielenski J, Durie P, Tullis DE (2004) Clinical manifestations of cystic fibrosis among patients with diagnosis in adulthood. Chest 126:1215–1224
Zeitlin P (2003) Emerging drug treatment for cystic fibrosis. Expert Opin Emerg Drugs 8:523–535
Choudari CP, Imperiale TF, Sherman S, Fogel E, Lehman GA (2004) Risk of pancreatitis with mutation of CF gene. Am J Gastroenterol 99:1358–1363
Ockenga J, Stuhrmann M, Ballmann M, Teich N, Keim V, Dork T, Manns MP (2000) Mutations of CF gene, not cationic trypsinogen gene, are associated with recurrent or chronic idiopathic pancreatitis. Am J Gastroenterol 95:2061–2067
Noone PG, Zhou Z, Silverman LM, Jowell PS, Knowles MR, Cohen JA (2001) CF gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology 121:1310–1319
Pezzilli R, Morselli-Labate AM, Mantovani V, Romboli E, Selva P, Migliori M, Corinaldesi R, Gullo L (2003) Mutations of CFTR gene in pancreatic disease. Pancreas 27:332–336
Frulloni L, Castellani C, Bovo P, Vaona B, Calore B, Liani C, Mastella G, Cavalliani G (2003) Natural history of pancreatitis associated with cystic fibrosis gene mutations. Dig Liver Dis 35:179–185
Durno C, Corey M, Zielenski J, Tullis E, Tsui LC, Durie P (2002) Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. Gastroenterology 123:1857–1864
Gelrud A, Sheth S, Banerjee S, Weed D, Shea J, Chuttani R, Howell DA, Telford JJ, Carr-Locke DL, Regan MM, Ellis L, Durie PR, Freedman SD (2004) Analysis of cystic fibrosis gene product (CFTR) function in patients with pancreatic divisum and recurrent acute pancreatitis. Am J Gastroenterol 99:1557–1562
Kopelman H, Forstner G, Durie P, Corey M (1989) Origins of chloride and bicarbonate secretory defects in the cystic fibrosis pancreas, as suggested by pancreatic function studies on control and CF subjects with preserved pancreatic function. Clin Invest Med 12:207–211
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Obideen, K., Wehbi, M., Hoteit, M. et al. Nocturnal Hydration—An Effective Modality to Reduce Recurrent Abdominal Pain and Recurrent Pancreatitis in Patients with Adult-Onset Cystic Fibrosis. Dig Dis Sci 51, 1744–1748 (2006). https://doi.org/10.1007/s10620-006-9185-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-006-9185-2